GROOVE BOTANICALS INC.
GRVEOTCEnergy · Crude Petroleum & Natural Gas · CO · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$130,834 | −$266,581 | −$175,514 | −$237,176 | −$2.8M | −$374,088 |
| Net income | −$130,834 | −$202,089 | −$120,726 | −$243,193 | −$2.5M | $100,314 |
| Total assets | $4,520 | $2,142 | $5,048 | $325,220 | $373,628 | $2.7M |
| Total liabilities | $1.1M | $762,699 | $443,346 | $1.2M | $921,448 | $1.1M |
| Equity | −$1.1M | −$760,557 | −$438,298 | −$1.0M | −$598,481 | $1.7M |
| EPS (diluted) | $-0.01 | $-0.01 | $0.00 | — | $0.15 | $0.01 |
| Shares out. | 59.6M | 59.6M | 57.6M | 18.2M | 18.2M | 16.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 11.8%
- Return on assets
- −2894.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 24654.4%
- Debt / equity
- —
- Book value / share
- $-0.02
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -27191.48distress
- Accruals / assets
- −518.0%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 17, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 18, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Kmissed a reporting deadline ↗Jun 30, 2025
- NT 10-Qmissed a reporting deadline ↗Feb 13, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Utek Corp10% owner | Jun 30, 2008 | Sell | 132,500 | $0.11 |
| Utek Corp10% owner | Apr 4, 2008 | Sell | 25,000 | $0.21 |
| Utek Corp10% owner | Mar 28, 2008 | Sell | 9,700 | $0.10 |
| Utek Corp10% owner | Mar 25, 2008 | Sell | 30,000 | $0.10 |
| Kaplan ThadDirector | Aug 7, 2007 | Sell | 2,000 | $0.62 |
| Kaplan ThadDirector | May 17, 2007 | Conversion | 107,547 | $0.00 |
| Barton Douglas WDirector | May 17, 2007 | Conversion | 107,547 | $0.00 |
| Utek Corp10% owner | Mar 28, 2007 | Grant | 36.7M | $0.02 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Changed auditorMay 22, 2026
- Prior financials not reliable (restatement)Aug 19, 2025
- Director / officer changeAug 1, 2024
- Changed auditorJun 26, 2024
- Changed auditorMay 10, 2024
- Changed auditorAug 29, 2023
- Shareholder voteOct 3, 2012
- Director / officer changeJul 17, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 22, 2026
- 10-QFORM 10-QFeb 20, 2026
- NT 10-QFeb 17, 2026
- 10-QFORM 10-QNov 19, 2025
- NT 10-QNov 18, 2025
- 10-K/AAug 25, 2025
- 10-QAug 19, 2025
- 8-KAug 19, 2025
- 10-K/AAug 15, 2025
- NT 10-QFORM 12B25: NT 10-QAug 15, 2025
- 10-KJul 16, 2025
- NT 10-KFORM 12B25: NT 10-KJun 30, 2025
- 10-QFeb 25, 2025
- NT 10-QFORM 12B25: NT 10-QFeb 13, 2025
- 10-QNov 14, 2024